US Anesthesia Partners names Dr. Kurt Jones Chief Clinical Officer

Process Development Chemistry sits at the nexus of discovery and manufacturing, turning early-stage synthetic routes into robust, scalable processes for our antibody-drug conjugate (ADC) programs. Our experienced team focuses on route scouting, reaction optimization, and the multi-kilogram scale-up of linkers, payloads, and conjugation intermediates, as well as seamless technology transfer to supp